The Joint stock: Company trims 2026 sales outlook after Q3
Published on 11/19/2026 at 03:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- The Joint Corp. lowered its 2026 system-wide sales outlook after consumer spending pressure weighed on comparable sales.
- The company authorized an additional $5 million for share repurchases and expects its year-end clinic count to decline.
- Refranchising and territory buybacks are supporting the transition toward a capital-light franchisor model.
The Joint Corp. lowered its 2026 system-wide sales outlook after reporting third-quarter results on November 5, 2026. In its third-quarter release, the chiropractic franchisor cited continued pressure on consumer spending.
Lower sales outlook
System-wide sales guidance for 2026 was reduced to $508 million-$512 million from $519 million-$552 million. Comparable sales for clinics open at least 13 months are now expected to decline between 3.5% and 2.5%, compared with the previous range of a 3% decline to 3% growth. Adjusted EBITDA guidance was maintained at $12.5 million-$13.5 million.
Third-quarter revenue increased to $13.6 million from $13.4 million a year earlier. System-wide sales fell to $123.3 million, while comparable sales declined 1.9%. Net income from continuing operations rose to $1.5 million from $290,000, but consolidated operations posted a net loss of $117,000 because of discontinued operations.
Capital allocation continues
The company repurchased approximately 461,000 shares for $3.8 million during the quarter. On November 3, the board authorized an additional $5 million for repurchases, extending the program through November 4, 2027, subject to market conditions and other factors.
The Joint also completed the reacquisition of regional developer rights for Texas on October 1 for $8 million in cash at closing, with up to $2 million in additional consideration tied to sales targets. The territory includes 141 franchised clinics.
Franchisor model takes shape
The Joint Corp. operates and franchises chiropractic clinics through The Joint Chiropractic network. Its services focus on routine and affordable chiropractic care, with operations centered on a nationwide U.S. clinic network from its headquarters in Scottsdale, Arizona. The company has shifted toward a capital-light, pure-play franchisor model as clinics are refranchised and regional developer territories are reacquired.
The broader U.S. market backdrop is covered in current S&P 500 reports.
More company coverage is available in more news and analyses on The Joint stock.
The Joint Corp. at a glance
- Company: The Joint Corp.
- ISIN: US47973J1025
- Ticker: JYNT
- Home exchange: Nasdaq
- Reporting period: Third quarter ended September 30, 2026
- Revenue: $13.6 million
- System-wide sales: $123.3 million
- 2026 system-wide sales guidance: $508 million-$512 million
- Continuing-operations income: $1.5 million
- Clinic count: 930 at September 30, 2026
